These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

522 related articles for article (PubMed ID: 25251256)

  • 1. Etoposide and carbo-or cisplatin combination therapy in refractory or relapsed Ewing sarcoma: a large retrospective study.
    van Maldegem AM; Benson C; Rutkowski P; Blay JY; van den Berg H; Placzke J; Rasper M; Judson I; Juergens H; Dirksen U; Gelderblom H
    Pediatr Blood Cancer; 2015 Jan; 62(1):40-4. PubMed ID: 25251256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retrospective Analysis of Outcomes of Patients with Relapsed, Refractory and Metastatic Sarcomas who have received Metronomic Chemotherapy.
    Devadas SK; Banavali S
    Gulf J Oncolog; 2019 May; 1(30):22-28. PubMed ID: 31242978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase II study of cisplatin and oral VP16 in patients with refractory or relapsed Ewing sarcoma.
    Owens C; Laurence V; Benboubker L; Defachelles AS; Cupissol D; Rubie H; Brisse H; Rey A; Ollivier L; Couanet D; Baunin C; Aït-Oukhatar CM; Oberlin O
    Cancer Chemother Pharmacol; 2013 Feb; 71(2):399-404. PubMed ID: 23161409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin in the treatment of Ewing sarcoma: Results of the first Brazilian collaborative study group for Ewing sarcoma family tumors-EWING1.
    Brunetto AL; Castillo LA; Petrilli AS; Macedo CD; Boldrini E; Costa C; Almeida MT; Kirst D; Rodriguez-Galindo C; Pereira WV; Watanabe FM; Pizza M; Benites E; Morais V; Gadelha A; Nakasato A; Abujamra AL; Gregianin LJ;
    Pediatr Blood Cancer; 2015 Oct; 62(10):1747-53. PubMed ID: 25917418
    [TBL] [Abstract][Full Text] [Related]  

  • 5. VIP (etoposide, ifosfamide, cisplatin) in adult patients with recurrent or refractory Ewing sarcoma family of tumors.
    El Weshi A; Memon M; Raja M; Bazarbashi S; Rahal M; El Foudeh M; Pai C; Allam A; El Hassan I; Ezzat A
    Am J Clin Oncol; 2004 Oct; 27(5):529-34. PubMed ID: 15596925
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An alternative treatment regimen of advanced seminoma with carboplatin, etoposide, and bleomycin instead of cisplatin-based therapy.
    Giesen E; Mager A; van Tinteren H; Rodenhuis S; Kerst JM
    Urol Oncol; 2013 Jan; 31(1):110-4. PubMed ID: 21458311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adult Ewing sarcoma: survival and local control outcomes in 36 patients with metastatic disease.
    Ahmed SK; Robinson SI; Okuno SH; Rose PS; Issa Laack NN
    Am J Clin Oncol; 2014 Oct; 37(5):423-9. PubMed ID: 23388557
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypoalbuminaemia is an independent predictor of poor outcome in metastatic Ewing's sarcoma family of tumours: a single institutional experience of 150 cases treated with uniform chemotherapy protocol.
    Biswas B; Rastogi S; Khan SA; Shukla NK; Deo SV; Agarwala S; Sharma DN; Thulkar S; Vishnubhatla S; Pathania S; Bakhshi S
    Clin Oncol (R Coll Radiol); 2014 Nov; 26(11):722-9. PubMed ID: 24919857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival and prognostic factors in adult patients with recurrent or refractory ewing sarcoma family tumours: a 13-years retrospective study in Turkey.
    Yildiz I; Sen F; Ekenel M; Darendeliler E; Bavbek S; Agaoglu F; Ozger H; Eralp L; Bilgic B; Basaran M
    In Vivo; 2014; 28(3):403-9. PubMed ID: 24815845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cyclophosphamide and topotecan as first-line salvage therapy in patients with relapsed ewing sarcoma at a single institution.
    Farhat R; Raad R; Khoury NJ; Feghaly J; Eid T; Muwakkit S; Abboud M; El-Solh H; Saab R
    J Pediatr Hematol Oncol; 2013 Jul; 35(5):356-60. PubMed ID: 23042020
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Chemotherapy in patients with refractory Ewing sarcoma].
    Raciborska A; Bilska K; Drabko K; Rogowska E; Chaber R; Pogorzała M; Wyrobek E; Połczyńska K; Rodriguez-Galindo C; Woźniak W
    Med Wieku Rozwoj; 2013; 17(2):117-25. PubMed ID: 23988368
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of cisplatin, carboplatin, and etoposide in metastatic nonsmall cell lung carcinoma. A phase II study of the Southwest Oncology Group.
    Figlin RA; Crowley JJ; Jacobs EL; Muirhead M; Goodwin JW; Rinehart JJ; Livingston RB
    Cancer; 1996 Sep; 78(5):998-1003. PubMed ID: 8780537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.
    Wessalowski R; Schneider DT; Mils O; Friemann V; Kyrillopoulou O; Schaper J; Matuschek C; Rothe K; Leuschner I; Willers R; Schönberger S; Göbel U; Calaminus G;
    Lancet Oncol; 2013 Aug; 14(9):843-52. PubMed ID: 23823158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validation of a multi-modal treatment protocol for Ewing sarcoma--a report from the polish pediatric oncology group.
    Raciborska A; Bilska K; Drabko K; Chaber R; Sobol G; Pogorzała M; Wyrobek E; Połczyńska K; Rogowska E; Rodriguez-Galindo C; Wożniak W
    Pediatr Blood Cancer; 2014 Dec; 61(12):2170-4. PubMed ID: 25163763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Do the time to chemotherapy response and the dose intensity have an impact on patient outcome in advanced non-small cell lung cancer?
    Radosavljevic D; Golubicic I; Gavrilovic D; Kezic I; Jelic S
    J BUON; 2009; 14(2):203-9. PubMed ID: 19650167
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemotherapy for small cell lung carcinoma: the Greenlane Hospital experience 1993-1995.
    Lee YC; McCrystal MR; Christmas TI
    N Z Med J; 1998 Nov; 111(1078):451-2, 453-4. PubMed ID: 9891564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide, carboplatin, and etoposide (ICE) reinduction chemotherapy in a large cohort of children and adolescents with recurrent/refractory sarcoma: the Children's Cancer Group (CCG) experience.
    Van Winkle P; Angiolillo A; Krailo M; Cheung YK; Anderson B; Davenport V; Reaman G; Cairo MS
    Pediatr Blood Cancer; 2005 Apr; 44(4):338-47. PubMed ID: 15503297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic factors and patterns of relapse in ewing sarcoma patients treated with chemotherapy and r0 resection.
    Pan HY; Morani A; Wang WL; Hess KR; Paulino AC; Ludwig JA; Lin PP; Daw NC; Mahajan A
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):349-57. PubMed ID: 25772182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Whole Lung Irradiation on Survival Outcome in Patients With Lung Relapsed Ewing Sarcoma.
    Scobioala S; Ranft A; Wolters H; Jabar S; Paulussen M; Timmermann B; Juergens H; Hassenpflug W; Klingebiel T; Elsayad K; Eich HT; Dirksen U
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(3):584-592. PubMed ID: 30244879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Post-relapse survival in patients with Ewing sarcoma.
    Ferrari S; Luksch R; Hall KS; Fagioli F; Prete A; Tamburini A; Tienghi A; DiGirolamo S; Paioli A; Abate ME; Podda M; Cammelli S; Eriksson M; Brach del Prever A
    Pediatr Blood Cancer; 2015 Jun; 62(6):994-9. PubMed ID: 25585917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.